human | Q5 |
P6178 | Dimensions author ID | 01261111032.73 |
P496 | ORCID iD | 0000-0001-6093-0726 |
P69 | educated at | Shanghai University | Q1343386 |
P108 | employer | PLA Eastern Theater Command General Hospital | Q6963655 |
P734 | family name | Liu | Q39000092 |
Liu | Q39000092 | ||
Liu | Q39000092 | ||
P106 | occupation | researcher | Q1650915 |
Q48077178 | A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy. |
Q33418553 | A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study |
Q92201878 | A risk stratification for systemic immunoglobulin light-chain amyloidosis with renal involvement |
Q85977117 | A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses |
Q35547522 | ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation |
Q57057038 | Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases |
Q37721523 | Acute lymphoblastic leukemia complicated by acute renal failure: a case report and review of the literature. |
Q80315976 | Amylin deposition in the kidney of patients with diabetic nephropathy |
Q36151634 | An elevated percentage of reticulated platelet is associated with increased mortality in septic shock patients. |
Q81858826 | Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis |
Q35748320 | Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury. |
Q54623855 | Association of interleukin-10 gene -592 A/C polymorphism with the clinical and pathological diversity of lupus nephritis. |
Q39031825 | BK Virus-Associated Nephropathy with Plasma Cell-Rich Infiltrates Treated by Bortezomib-Based Regimen. |
Q36166909 | CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production |
Q37704862 | Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection. |
Q33582865 | Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells |
Q36556406 | Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis |
Q41617980 | Chronic Kidney Disease in Patients With Lacunar Stroke: Association With Enlarged Perivascular Spaces and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease |
Q35527551 | Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents |
Q36843420 | Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection |
Q44373076 | Class V lupus nephritis: a clinicopathologic study in 152 patients |
Q87753619 | Clearance of myoglobin by high cutoff continuous veno-venous hemodialysis in a patient with rhabdomyolysis: a case report |
Q53589620 | Clinical and morphological features of collagen type III glomerulopathy: a report of nine cases from a single institution. |
Q53640703 | Clinical and morphological features of fibronectin glomerulopathy: a report of ten patients from a single institution. |
Q43637818 | Clinical and pathological features of dense deposit disease in Chinese patients. |
Q84456177 | Clinical and pathological spectrums of aristolochic acid nephropathy |
Q60128791 | Clinical features and renal outcome in lupus patients with diffuse crescentic glomerulonephritis |
Q46761264 | Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy. |
Q50559460 | Clinicopathological features and prognosis of Chinese patients with acute post-streptococcal glomerulonephritis. |
Q50426715 | Coexistence of Fabry disease and IgA nephropathy: a report of two cases |
Q36746109 | Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes |
Q34021733 | Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis |
Q112704001 | Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction |
Q50718204 | Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate. |
Q51338744 | Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study. |
Q36151753 | D-dimer as an early marker of severity in patients with acute superior mesenteric venous thrombosis |
Q82082999 | De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection |
Q35964488 | De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy |
Q33415284 | Decreased platelet count in patients receiving continuous veno-venous hemofiltration: a single-center retrospective study |
Q82814002 | Delayed renal function recovery from drug-induced acute interstitial nephritis |
Q37194020 | Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy |
Q46562321 | Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases |
Q45350198 | Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy |
Q37086690 | Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis |
Q47292219 | Dissection of Glomerular Transcriptional Profile in Patients with Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function |
Q37411622 | Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids |
Q37672842 | Effect of equivalent doses of fentanyl, sufentanil, and remifentanil on the incidence and severity of cough in patients undergoing abdominal surgery: A prospective, randomized, double-blind study. |
Q124841977 | Effectiveness of renin–angiotensin–aldosterone system blockers in patients with Alport syndrome: a systematic review and meta-analysis |
Q50582511 | Endothelial injury in transplant glomerulopathy is correlated with transcription factor T-bet expression. |
Q28292149 | Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy |
Q33206211 | Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies |
Q80238428 | Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors |
Q38589994 | Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review. |
Q51391472 | Evaluation of metabolic risk marker in obesity-related glomerulopathy. |
Q30963123 | Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker |
Q46740206 | Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis |
Q36482167 | Evaluation of vascular lesions using circulating endothelial cells in renal transplant patients |
Q24621515 | Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA |
Q35919154 | Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas. |
Q46875970 | Fabry disease: renal biopsy-proven cases from China |
Q36317898 | Fast track surgery vs. conventional management in the perioperative care of retroperitoneal laparoscopic adrenalectomy |
Q35342135 | Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuret |
Q36751698 | GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway |
Q37704945 | Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen. |
Q35116647 | Genome-wide screen of DNA methylation changes induced by low dose X-ray radiation in mice. |
Q35086477 | Glomerular endothelial cell injury and cross talk in diabetic kidney disease |
Q73745989 | Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis |
Q112721410 | Glucocorticoid receptor wields chromatin interactions to tune transcription for cytoskeleton stabilization in podocytes |
Q77410513 | Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus |
Q34302891 | Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy |
Q35121215 | Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion |
Q34429806 | Heart-type fatty acid binding protein is associated with proteinuria in obesity |
Q96433612 | Identification of glomerular lesions and intrinsic glomerular cells types in kidney diseases via deep learning |
Q37249853 | Immunophenotyping in BK virus allograft nephropathy distinct from acute rejection |
Q33828188 | Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis |
Q92061118 | Improvement of Outcomes in Patients with Lupus Nephritis: Management Evolution in Chinese Patients from 1994 to 2010 |
Q38821479 | Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy. |
Q35081363 | Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial |
Q97518144 | Influence of guideline adherence and parameter control on the clinical outcomes in patients with diabetic nephropathy |
Q35834731 | Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury. |
Q39030102 | Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy |
Q33594949 | Initial transcatheter thrombolysis for acute superior mesenteric venous thrombosis |
Q73424003 | Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy? |
Q46874561 | Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil |
Q31122594 | Lipoprotein glomerulopathy: clinical features and pathological characteristics in Chinese. |
Q38086275 | Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population |
Q80224160 | Long-term outcome of Chinese patients with membranous lupus nephropathy |
Q88216159 | Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria |
Q40355738 | Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease |
Q85030658 | Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population |
Q34371874 | Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report. |
Q46076689 | Melatonin, a potent regulator of hemeoxygenase-1, reduces cardiopulmonary bypass-induced renal damage in rats |
Q33684071 | Mercury-induced membranous nephropathy: clinical and pathological features |
Q44074013 | Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. |
Q34450449 | NSFC health research funding and burden of disease in China |
Q38123395 | Nephrology in china |
Q84538135 | Nephrotic proteinuria and hypertension |
Q46635478 | Obesity-related glomerulopathy in China: a case series of 90 patients |
Q34075430 | Obesity-related glomerulopathy: body mass index and proteinuria |
Q33224747 | Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples |
Q46511556 | Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy |
Q41482711 | PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics sugge |
Q38669608 | Peritoneal dialysis treatment for severe lupus nephritis patients complicated with essential organ dysfunction |
Q81523212 | Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection |
Q34423734 | Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation |
Q41921297 | Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies |
Q51487232 | Podocyte lesions in patients with obesity-related glomerulopathy. |
Q36923664 | Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS |
Q41549812 | Prediction of renal outcomes in patients with crescentic lupus nephritis. |
Q34534855 | Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection |
Q84388638 | Presence of foam cells in kidney interstitium is associated with progression of renal injury in patients with glomerular diseases |
Q82087278 | Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors |
Q41710382 | Randomized Controlled Trial to Evaluate Regional Citrate Anticoagulation Plus Low-Dose of Dalteparin in Continuous Veno-Venous Hemofiltration. |
Q85666043 | Recurrent Proliferative Glomerulonephritis With Monoclonal IgG Deposits After a Renal Transplant Which Was Insensitive to Pulse Therapy Remitted by Double Filtration Plasmapheresis |
Q46459703 | Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation |
Q36242244 | Regulation of MUTYH, a DNA Repair Enzyme, in Renal Proximal Tubular Epithelial Cells |
Q34455143 | Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS |
Q82984030 | Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients |
Q87447199 | Renal histologic changes and the outcome in patients with diabetic nephropathy |
Q35147984 | Renal involvement in non-Hodgkin lymphoma: proven by renal biopsy |
Q79438963 | Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection |
Q53136882 | Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease. |
Q86523780 | Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation |
Q41536987 | Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome |
Q36003095 | Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS. |
Q85745404 | Roles of mast cells and monocyte chemoattractant protein-1 in the renal injury of obesity-related glomerulopathy |
Q40135788 | Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk. |
Q77227682 | Significance of anti-neutrophil cytoplasmic antibodies in patients with pauci-immune crescentic glomerulonephritis |
Q81411815 | Significance of vascular endothelial growth factor expression in renal tissue of patients with preeclamptic nephropathy |
Q46187788 | Successful renal transplantation in a patient with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis: effect of early plasma exchange and mycophenolate mofetil |
Q36906037 | Successful treatment of class V+IV lupus nephritis with multitarget therapy. |
Q46900024 | Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients |
Q37733530 | The Association of a Genetic Variant in SCAF8-CNKSR3 with Diabetic Kidney Disease and Diabetic Retinopathy in a Chinese Population. |
Q38263790 | The application of urinary proteomics for the detection of biomarkers of kidney diseases. |
Q43847324 | The clinical and pathological characteristics of Chinese patients with pauci-immune crescent glomerulonephritis. |
Q44469697 | The clinical course and long-term outcome of primary focal segmental glomerulosclerosis in Chinese adults |
Q35026460 | The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients |
Q40752049 | The evolution of morphological variants of focal segmental glomerulosclerosis: a repeat biopsy-based observation. |
Q34269169 | The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria |
Q34462626 | The primary glomerulonephritides: a systems biology approach |
Q44076732 | The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases. |
Q46839820 | The relationship between body fat distribution and renal damage in Chinese with obesity |
Q34632532 | The relationship between obesity and diabetic nephropathy in China |
Q87408384 | The spectrum of biopsy-proven kidney diseases in elderly Chinese patients |
Q36897652 | Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial |
Q80252616 | Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil |
Q46187814 | Tripterygium wilfordii hook f increase the blood concentration of tacrolimus |
Q39717376 | Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. |
Q98160830 | Types of M protein and clinicopathological profiles in patients with monoclonal gammopathy of renal significance |
Q34794421 | Using an isolated rat kidney model to identify kidney origin proteins in urine |
Q35735968 | Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study |
Q74563581 | [Impact of platelet derived growth factor in the glomeruli of active lupus nephritis] |
Q77511776 | [Treatment of severe acute renal failure with continuous renal replacement therapy] |
Search more.